To assess the clinical features, development of metastases, and survival rate of patients with local recurrence after the resection of osteosarcoma in a large series. Five hundred and thirty (530) patients with high-grade osteosarcoma were treated between 1989 and 1998. Fifty-four patients (10%) developed local recurrence after resection and adjuvant chemotherapy. There were 38 men and 16 women with a mean age of 19 years (range 6–50). The mean follow up was 39 months (range 7–120 months). Forty-three patients (79%) had clear resection margins microscopically, while in 8 patients (15%) microscopic tumour was found at the resection margin, and contaminated excision was performed in 3 patients. Histological response was category 1 in 24% of the patients, and category 2 in 76%. Clinical features, treatment, and prognosis were analyzed. Survival rates were examined using Kaplan-Meier Analysis. The average interval between the first resection and local recurrence was 15 months (range 2–109 months). Forty-one patients (76%) had local recurrence in deep soft tissue, 7 in bone, and 6 in subcutaneous tissue. Twenty-six patients (49%) had lung metastasis at the time of local recurrence, while 21 patients (38%) developed it later. Thirty patients (57%) were treated with resection of the recurrent lesion and 18 (32%) were treated with amputation. 1-, 3-, and 5-year survival rates after local recurrence were 0.57, 0.38, and 0.22 respectively.
87% of patients with local recurrence developed metastases either concurrently or at a later date. Immediate amputation did achieve local tumor control. However, the survival rate was not statistically higher. 87% of the local recurrence arose in soft tissue. Therefore, careful attention should be paid to secure the wide margin around biopsy tract, muscle insertion to the affected bone, and neurovascular bundle at the time of initial resection.
Chondrosarcoma is the second most common bone tumour and occurs in the third to sixth decades of life. It most commonly arises in the pelvis and proximal femur. We performed a clinical, operative and histological review of all patients seen at our unit with chondro-sarcoma of the pelvis over a ten-year period. We iden-tified 36 cases of chondrosarcoma of the pelvis and a retrospective analysis of cases was performed examining the rate of tumour recurrence and mortality rate with respect to tumour grade, anatomical site and type of surgery performed. 25 patients had a primary tumour diagnosed, 6 tumours were secondary to MHE and the remaining 5 were recurrent tumours. The tumours were situated in the acetabulum (14), the pubic / ischial rami (7), and the iliac wing (15). Surgical procedures included wide local excision (18), wide local excision and total hip arthroplasty (4), hemipelvectomy and endoprosthesis (13), and hind quarter amputation (1). The median follow up period was 48 months. 10 year cumulative survival rate was 40% and poor survival was associated with iliac tumours and higher grade tumours. Mean time to recurrence was 18.5 months and cumulative 10 year recurrence rates were 44%. Increased recurrence was associated with iliac and rami tumours and those excised by local resection alone. High tumour grade was not associated with increased recurrence in our study. The overall surgical complication rate of the operative procedures was 27%. These included dislocation and infection of prosthesis. Conclusions: This disease continues to be a surgical challenge with a clear association between more radical surgery and low tumour recurrence rates. However this must be balanced against the potentially devastating complications associated with this major reconstructive surgery.
The aim of this study is to evaluate the early results of gleno-humeral reconstruction after tumour excision with a new design of endoprosthesis. The prosthesis is a fixed fulcrum gleno-humeral replacement consisting of a hydroxyapatite (HA) coated glenoid component with a polyethylene liner and a cemented stem with HA coated collar. Between 1997 and 2000 we inserted the prosthesis into 15 patients with primary bone tumours of the proximal humerus. There were nine males and six females with a mean age of 38 years (range: 8–71 years). Twelve stems were cemented and three uncemented. Two skeletally immature patients had an extendible stem inserted, one subsequently having a successful lengthening procedure. The mean follow-up was 28 months (range: 12–41 years). Functional outcome was assessed using the Musculoskeletal Tumour Society (MTS) scoring system. There were two early dislocations and one superficial wound infection. Three patients died of their disease and one underwent forequarter amputation for local recurrence. The remaining eleven had satisfactory functional outcomes with a mean MTS score of 81%. Radiologically there has been no evidence of early loosening. Microscopic analysis of the components in the amputated arm showed excellent osseointegration around the HA coated components.
We have reviewed 13 operations on 11 patients using curettage and polymethylmethacrylate cement for giant-cell tumour of bone (GCT) to assess the value of radiology in the early detection of recurrence. There were four recurrences, the most specific radiological sign on plain radiography was lysis of 5 mm or more at the cement-bone interface. This preceded clinical signs by a mean of four months and was identified at a mean of 3.75 months after operation. There was not always a complete sclerotic margin around the cement, but when it was present, there was never evidence of recurrence. MRI was helpful in assessing cases with evidence of recurrence. Frequent surveillance with plain radiography should continue for one year after operation irrespective of clinical signs of recurrence. When the appearance of the plain radiographs suggests recurrence, MRI should be performed and followed by image-guided needle biopsy.
Needle biopsies, performed on 208 consecutive patients and interpreted at the London Bone Tumour Service over a two-year period, were reviewed. A correct diagnosis was reached in 97% (133 out of 137) using this technique alone. Needle biopsy is safe and accurate when undertaken in consultation within a bone tumour service; it offers considerable advantages to both patient and surgeon over conventional open biopsy.
We have reviewed 20 cases of parosteal osteosarcoma treated by wide local resection and prosthetic replacement and followed up for six to 17 years. Limb function was excellent in 85%. One patient with grade III histological disease developed pulmonary metastases. Four patients had local recurrences, which were related to repeated preliminary biopsies, inappropriate siting of biopsy and vascular encroachment by the tumour. After this mode of treatment, the outcome was not related to medullary invasion by the tumour.
There are differences of opinion about the pathogenesis of Perthes' disease. All are agreed that it is due to ischaemia, but the cause of this and the size and number of infarctions are in dispute. Through the generosity of the contributors six whole femoral heads and core biopsies of five other cases have been studied radiographically and histologically. The findings ranged from an ischaemic arrest of ossification in the capital articular cartilage without infarction to multiple complete infarctions of the epiphysial bone. The ensuing reparative process contributes to the pathology, which is of a range to warrant grading or grouping.